Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 253, doi. 10.1002/pros.20150
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2005 AND VI 62 AND IP 3
Results: 12
1
2
Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kineticsIstvn Laczk and David L. Hudson contributed equally to the study.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 260
- By:
- Publication type:
- Article
3
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 267
- By:
- Publication type:
- Article
4
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 275, doi. 10.1002/pros.20146
- By:
- Publication type:
- Article
5
Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 282, doi. 10.1002/pros.20143
- By:
- Publication type:
- Article
6
Ability of PSA-positive circulating macrophages to detect prostate cancer.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 290, doi. 10.1002/pros.20141
- By:
- Publication type:
- Article
7
Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 299
- By:
- Publication type:
- Article
8
Stable expression of C/EBPa in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 209, doi. 10.1002/pros.20136
- By:
- Publication type:
- Article
9
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 224, doi. 10.1002/pros.20134
- By:
- Publication type:
- Article
10
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 233, doi. 10.1002/pros.20133
- By:
- Publication type:
- Article
11
Explaining racial differences in prostate cancer in the United States: Sociology or biology?Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 243, doi. 10.1002/pros.20052
- By:
- Publication type:
- Article
12
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 217, doi. 10.1002/pros.20135
- By:
- Publication type:
- Article